-- Developing comprehensive brand protection strategies
-- Deterring illicit replication of genuine goods, packaging and product
configuration
-- Preventing re-use of genuine packaging & containers for fake goods
-- Contributing to the detection and prosecution of those who make and
trade in fakes
-- Monitoring and identifying genuine goods within the supply chain
According to ACG, the ultimate aim of this coalition of companies "is to
change society's perception of counterfeiting as a harmless activity, by
exposing the worldwide economic and social cost of intellectual property
crime."
Applied DNA's increased presence in the UK is strengthened by its DNA
Authentication Laboratory based in Huddersfield, Yorkshire. APDN is working
closely with the UK Police in the forensic authentication of SigNature®
DNA-marked evidence. In addition, the application of DNA taggants can be
used to help protect genuine products such as Made-in-Britain wool and
cashmere luxury apparel, and pharmaceutical and medical devices that can
help to save lives. The value of joining ACG is that it will provide APDN
with increased exposure to a global network of companies focused on
preventing counterfeit and gray market diversion.
About ACG
ACG is a not-for-profit trade association founded in the UK in 1980
representing nearly 200 organizations globally operating in, or providing
specialist advice to, most industry sectors where counterfeiting is an
issue.
About APDN
APDN sells patented DNA security solutions to protect products, brands and
intellectual property from counterfeiting and diversion. SigNature DNA is a
botanical mark used to authenticate products in a unique manner that
essentially cannot be copied. APDN also provides BioMaterial GenoTyping™
by detecting genomic DNA in natural materials to authenticate finished
products. Both technologies protect brands and products in a wide range of
industries and provide a forensic chain of evidence that can be used to
prosecute perpetrators. To learn more and to view all APDN press releases,
go to (www.adnas.com).
The statements made by APDN may be forward-looking in nature and are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements describe APDN's future
plans, projections, strategies and expectations, and are based on
assumptions and involve a number of risks and uncertainties, many of which
are beyond the control of APDN. Actual results could differ materially from
those projected due to our short operating history, limited financial
resources, limited market acceptance, market competition and various other
factors detailed from time to time in APDN's SEC reports and filings,
including our Annual Report on Form 10-K, filed on December 16, 2008 and
our subsequent quarterly reports on Form 10-Q. APDN undertakes no
obligation to update publicly any forward-looking statements to reflect new
information, events or circumstances after the date hereof to reflect the
occurrence of unanticipated events.
Contact Information: INVESTOR RELATIONS: Debbie Bailey 631-444-8090 fax: 631-444-8848 MEDIA RELATIONS: Janice Meraglia 631-444-6293 fax: 631-444-8848 FCMN Contact: Web site: http://www.ADNAS.com